SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival
Open accessAbstract
SHIP is an inositol 5' phosphatase that hydrolyzes the PI3'K product PI(3,4,5)P3. We show that SHIP-deficient mice exhibit dramatic chronic hyperplasia of myeloid cells resulting in splenomegaly, lymphadenopathy, and myeloid infiltration of vital organs. Neutrophils and bone marrow-derived mast cells from SHIP-/- mice are less susceptible to programmed cell death induced by various apoptotic stimuli or by growth factor withdrawal. Engagement of IL3-R and GM-CSF-R in these cells leads to increased and prolonged PI3'K-dependent PI(3,4,5)P3 accumulation and PKB activation. These data indicate that SHIP is a negative regulator of growth factor-mediated PKB activation and myeloid cell survival.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Conditional Inpp5d knockdown in microglia avoids the developmental effects that can occur in constitutive knockouts.
“This strategy also avoids the developmental effects that can occur in constitutive knockouts.16,17”
From Microglial <i>INPP5D</i> limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [16]
The 'Generation of SHIP-deficient mice' section reports that mice lacking SHIP from birth had enlarged spleens apparent by four weeks and progressive abnormalities in myeloid cells. This supports concern about effects of a constitutive knockout, but the paper does not examine conditional Inpp5d knockdown in microglia or show that it avoids developmental effects. Page numbers were not available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measuredMicroglial activation and actin remodeling are processes that can be mediated by Inpp5d.
“which are both processes that can be mediated by Inpp5d. 6 , 20”
From Loss of <i>Inpp5d</i> has disease‐relevant and sex‐specific effects on glial transcriptomes (2024) · cites this paper as [6]
The paper’s Abstract (page unavailable) says PI3K and phospholipid-regulated signaling are implicated in cytoskeletal reorganization, and the SHIP-regulates-PKB section describes SHIP’s role in that signaling pathway. This provides indirect support for a connection to actin remodeling, but the paper does not show SHIP mediating actin remodeling or address microglial activation. (LLM, conf=0.73)
Experimental — accuracy not yet measuredUpon binding to PI(3,4,5)P3, the 5' phosphatase catalytic domain phosphorylates PI(3,4,5)P3 to generate PI(3,4)P2, which can bind to the C2 domain near the C-terminus.
“Upon binding to PI(3,4,5)P3, the 5’ phosphatase catalytic domain phosphorylates PI(3,4,5)P3 to generate PI(3,4)P2, which can bind to the C2 domain near the C-terminus [92, 107, 108].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [92]
The passage labeled Abstract (page unavailable) says SHIP hydrolyzes PI(3,4,5)P3 to generate PI(3,4)P2. It does not say the phosphatase phosphorylates PI(3,4,5)P3, and the passages do not support the claimed binding of PI(3,4)P2 to a C-terminal C2 domain. (LLM, conf=0.90)
Experimental — accuracy not yet measuredSHIP1 is a phosphatase involved in phosphoinositide signaling.
“SHIP1 is a phosphatase involved in phosphoinositide signaling.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [92]
PI(3,4,5)P3 can be converted back to PI(4,5)P2 by PTEN or converted into PI(3,4)P2 by SHIP1, which negatively regulates PI3K/Akt signaling.
“PI(3,4,5)P3 can be converted back to PI(4,5)P2 by the protein phosphatase and tensin homology (PTEN) or converted into PI(3,4)P2 by SHIP1, which negatively regulates PI3K/Akt signaling (Fig. 2) [89–92].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104 · see citing works
Alessi, D., James, S., Downes, C., Holmes, A. B., Gaffney, P., Reese, C., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 3,047 · see citing works
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551 · see citing works
Self-citationPI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,692 · see citing works
Mechanisms and consequences of activation of protein kinase B/Akt
Downward, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80149-x · Cited by 1,304 · see citing works
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., KAAY, J. V. D., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,161 · see citing works
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.19.11211 · Cited by 1,149 · see citing works
Rozakis-Adcock, M., McGlade, J. C., Mbamalu, G., Pelicci, G., Daly, R. J., Li, W., Batzer, A., Thomas, S. Μ., Brugge, J. S., Pelicci, P. G., et al. (1992) · Nature · doi:10.1038/360689a0 · Cited by 973 · see citing works
Ono, M., Bolland, S. M., Tempst, P., & Ravetch, J. V. (1996) · Nature · doi:10.1038/383263a0 · Cited by 781 · see citing works
RAFF, M. C. (1998) · Nature · doi:10.1038/24055 · Cited by 692 · see citing works
Damen, J. E., Liu, L., Rosten, P., Humphries, R. K., Jefferson, A. B., Majerus, P. W., & Krystal, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1689 · Cited by 633 · see citing works
Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G., & Humphries, R. K. (1998) · Genes & Development · doi:10.1101/gad.12.11.1610 · Cited by 556 · see citing works
Akt Signaling--Linking Membrane Events to Life and Death Decisions
Hemmings, B. A. (1997) · Science · doi:10.1126/science.275.5300.628 · Cited by 517 · see citing works
Deletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling
Ono, M., Okada, H., Bolland, S. M., Yanagi, S., Kurosaki, T., & Ravetch, J. V. (1997) · Cell · doi:10.1016/s0092-8674(00)80337-2 · Cited by 488 · see citing works
Klippel, A., Kavanaugh, W. M., Pot, D., & Williams, L. T. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.338 · Cited by 479 · see citing works
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
Lioubin, M. N., Algate, P. A., Tsai, S., Carlberg, K., Aebersold, A., & Rohrschneider, L. R. (1996) · Genes & Development · doi:10.1101/gad.10.9.1084 · Cited by 418 · see citing works
Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5
Miyajima, A., Mui, A. L.-F., Ogorochi, T., & Sakamaki, K. (1993) · Blood · doi:10.1182/blood.v82.7.1960.bloodjournal8271960 · Cited by 414 · see citing works
Huber, M., Helgason, C. D., Damen, J. E., Liu, L., Humphries, R. K., & Krystal, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11330 · Cited by 314 · see citing works
Pesesse, X., Deleu, S., Smedt, F. D., Drayer, L., & Erneux, C. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7538 · Cited by 237 · see citing works
Schmid, I., Uíttenbogaart, C. H., & Giorgi, J. V. (1994) · Cytometry · doi:10.1002/cyto.990150104 · Cited by 228 · see citing works
Regulation of Proliferation, Differentiation and Survival by the IL-3/IL-5/GM-CSF Receptor Family
de Groot, R. P., Coffer, P. J., & Koenderman, L. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00023-0 · Cited by 215 · see citing works
Liu, Q., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Jones, J. V., Sarao, R., Kozieradzki, I., Ohashi, P. S., Penninger, J. M., & Dumont, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1333 · Cited by 205 · see citing works
Self-citationDamen, J., Liu, L., Cutler, R., & Krystal, G. (1993) · Blood · doi:10.1182/blood.v82.8.2296.2296 · Cited by 193 · see citing works
Kimura, T., Sakamoto, H., Appella, E., & Siraganian, R. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13991 · Cited by 141 · see citing works
Liu, L., Damen, J. E., Hughes, M. R., Babić, I., Jirik, F. R., & Krystal, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8983 · Cited by 119 · see citing works
Lioubin, M. N., Myles, G. M., Carlberg, K., Bowtell, D. D. L., & Rohrschneider, L. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5682-5691.1994 · Cited by 117 · see citing works
Liu, Q., Shalaby, F., Jones, J., Bouchard, D., & Dumont, D. J. (1998) · Blood · doi:10.1182/blood.v91.8.2753.2753_2753_2759 · Cited by 95 · see citing works
Self-citationCrowley, M. T., Harmer, S. L., & DeFranco, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1145 · Cited by 85 · see citing works
Regulation of Phosphatidylinositol 3,4,5-Trisphosphate 5′-Phosphatase Activity by Insulin
Guilherme, A., Klarlund, J. K., Krystal, G., & Czech, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29533 · Cited by 36 · see citing works
Sasaki, T., Hazeki, K., Hazeki, O., Ui, M., & Katada, T. (1996) · Biochemical Journal · doi:10.1042/bj3151035 · Cited by 21 · see citing works
Self-citation
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,041 · see citing works
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · see citing works
Ravetch, J. V., & Bolland, S. M. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,653 · see citing works
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638 · see citing works
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,631 · see citing works
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583 · see citing works
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535 · see citing works
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,278 · see citing works
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J. F., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204 · see citing works
PI3K/Akt and apoptosis: size matters
Franke, T. F., Hornik, C., Segev, L., Shostak, G. A., & Sugimoto, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207115 · Cited by 1,184 · see citing works
PI3K/AKT signaling pathway and cancer: an updated review
Martini, M., Santis, M. C. D., Braccini, L., Gulluni, F., & Hirsch, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912836 · Cited by 1,176 · see citing works
Function of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A., Stanford, W. L., Bolon, B. N., Wakeham, A. C., Itié, A., Bouchard, D., Kozieradzki, I., et al. (2000) · Science · doi:10.1126/science.287.5455.1040 · Cited by 1,027 · see citing works
Self-citationBrognard, J., Clark, A. S., Ni, Y., & Dennis, P. A. (2001) · PubMed · Cited by 885 · see citing works
The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKB
Kandel, E., & Hay, N. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4690 · Cited by 867 · see citing works
Neutrophils and acute lung injury
Abraham, E. H. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057843.47705.e8 · Cited by 847 · see citing works
TRB3: A <i>tribbles</i> Homolog That Inhibits Akt/PKB Activation by Insulin in Liver
Du, K., Herzig, S., Kulkarni, R. N., & Montminy, M. (2003) · Science · doi:10.1126/science.1079817 · Cited by 842 · see citing works
Inositol phosphatase SHIP1 is a primary target of miR-155
O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902636106 · Cited by 826 · see citing works
Regulation of mast-cell and basophil function and survival by IgE
Kawakami, T., & Galli, S. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri914 · Cited by 632 · see citing works
Negative Regulation of Cytokine Signaling Pathways
Yasukawa, H., Sasaki, A. T., & Yoshimura, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.143 · Cited by 596 · see citing works
Activation of the PI3K/Akt pathway and chemotherapeutic resistance
West, K. A., Castillo, S. S., & Dennis, P. A. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00120-6 · Cited by 583 · see citing works
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G. G., Griffiths, E. K., Krawczyk, C. M., Richardson, C. D., AITKEN, K. J., et al. (2001) · Nature · doi:10.1038/35053086 · Cited by 557 · see citing works
Self-citationA PtdInsP3- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity
Weiner, O. D., Neilsen, P. O., Prestwich, G. D., Kirschner, M. W., Cantley, L. C., & Bourne, H. R. (2002) · Nature Cell Biology · doi:10.1038/ncb811 · Cited by 506 · see citing works
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Babar, I., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201516109 · Cited by 496 · see citing works
The role of PI3K in immune cells
Koyasu, S. (2003) · Nature Immunology · doi:10.1038/ni0403-313 · Cited by 486 · see citing works
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
Oudit, G. Y. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.015 · Cited by 467 · see citing works
PTEN function: how normal cells control it and tumour cells lose it
Leslie, N. R., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20040825 · Cited by 447 · see citing works
PTEN: The down side of PI 3-kinase signalling
Leslie, N. R., & Downes, C. P. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00234-0 · Cited by 415 · see citing works
Structure, function, and biology of SHIP proteins
Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y., & Lucas, D. M. (2000) · Genes & Development · doi:10.1101/gad.14.5.505 · Cited by 294 · see citing works
Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1
Nishio, M., Watanabe, K., Sasaki, J., Taya, C., Takasuga, S., Iizuka, R., Balla, T., Yamazaki, M., Watanabe, H., Itoh, R., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1515 · Cited by 288 · see citing works
Self-citationSakamoto, K. M., & Frank, D. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1137 · Cited by 278 · see citing works
Mammalian phosphoinositide kinases and phosphatases
Sasaki, T., Takasuga, S., Sasaki, J., Kofuji, S., Eguchi, S., Yamazaki, M., & Suzuki, A. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.06.001 · Cited by 274 · see citing works
Self-citationRegulation of Akt Signaling by Sirtuins
Pillai, V. B., Sundaresan, N. R., & Gupta, M. P. (2014) · Circulation Research · doi:10.1161/circresaha.113.300536 · Cited by 260 · see citing works
Akt Induces Osteoclast Differentiation through Regulating the GSK3β/NFATc1 Signaling Cascade
Moon, J. B., Kim, J. H., Kim, K., Youn, B. U., Ko, A., Lee, S. Y., & Kim, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101254 · Cited by 254 · see citing works
Takeshita, S., Namba, N., Zhao, J. J., Jiang, Y., Genant, H. K., Silva, M. J., Brodt, M. D., Helgason, C. D., Kalesnikoff, J., Rauh, M. J., et al. (2002) · Nature Medicine · doi:10.1038/nm752 · Cited by 250 · see citing works
Toll-like receptor signal transduction
Krishnan, J., Selvarajoo, K., Tsuchiya, M., Lee, G., & Choi, S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.47 · Cited by 247 · see citing works
Neutrophil β2 integrins: moderators of life or death decisions
Mayadas, T. N., & Culleré, X. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.05.002 · Cited by 247 · see citing works
Negative Regulation of Immunoreceptor Signaling
Veillette, A., Latour, S., & Davidson, D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.130710 · Cited by 242 · see citing works
Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination
Suzuki, A., Kaisho, T., Ohishi, M., Tsukio-Yamaguchi, M., Tsubata, T., Koni, P. A., Sasaki, T., Mak, T. W., & Nakano, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021101 · Cited by 235 · see citing works
Self-citationSHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Pearse, R. N., Kawabe, T., Bolland, S. M., Guinamard, R., Kurosaki, T., & Ravetch, J. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80074-6 · Cited by 215 · see citing works
Thompson, J. E., & Thompson, C. B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.103 · Cited by 206 · see citing works
ITAMs versus ITIMs: striking a balance during cell regulation
Billadeau, D. D., & Leibson, P. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14843 · Cited by 197 · see citing works
ITAMs versus ITIMs: striking a balance during cell regulation
Billadeau, D. D., & Leibson, P. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214843 · Cited by 192 · see citing works
Dok-3, a Novel Adapter Molecule Involved in the Negative Regulation of Immunoreceptor Signaling
Lemay, S., Davidson, D., Latour, S., & Veillette, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2743-2754.2000 · Cited by 190 · see citing works
Taylor, V., Wong, M. P., Brandts, C., Reilly, L., Dean, N. M., Cowsert, L. M., Moodie, S. A., & Stokoe, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6860-6871.2000 · Cited by 182 · see citing works
Yamanashi, Y., Tamura, T., Kanamori, T., Yamane, H., Nariuchi, H., Yamamoto, T. S., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.1.11 · Cited by 181 · see citing works
Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow Transplantation
Wang, J.-W., Howson, J. M., Ghansah, T., Desponts, C., Ninos, J. M., May, S. L., Nguyen, K. H. T., Toyama-Sorimachi, N., & Kerr, W. G. (2002) · Science · doi:10.1126/science.1068438 · Cited by 178 · see citing works
Dutton, A., Reynolds, G. M., Dawson, W. O., Young, L. S., & Murray, P. G. (2005) · The Journal of Pathology · doi:10.1002/path.1725 · Cited by 177 · see citing works
Wada, T., Sasaoka, T., Funaki, M., Hori, H., Murakami, S., Ishiki, M., Haruta, T., Asano, T., Ogawa, W., Ishihara, H., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1633-1646.2001 · Cited by 172 · see citing works
Excitable Signal Transduction Networks in Directed Cell Migration
Devreotes, P. N., Bhattacharya, S., Edwards, M., Iglesias, P. A., Lampert, T. J., & Miao, Y. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060739 · Cited by 170 · see citing works
Scheid, M. P., Huber, M., Damen, J. E., Hughes, M. R., Kang, V. H., Neilsen, P. O., Prestwich, G. D., Krystal, G., & Duronio, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106755200 · Cited by 166 · see citing works
Harder, K. W., Parsons, L. M., Armes, J. E., Evans, N., Kountouri, N., Clark, R., Quilici, C., Grail, D., HODGSON, G. S., Dunn, A. R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00208-4 · Cited by 165 · see citing works
The roles of Dok family adapters in immunoreceptor signaling
Mashima, R., Hishida, Y., Tezuka, T., & Yamanashi, Y. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00844.x · Cited by 151 · see citing works
T-cell signalling and autoimmunity: molecular mechanisms of disease
Ohashi, P. S. (2002) · Nature reviews. Immunology · doi:10.1038/nri822 · Cited by 148 · see citing works
Akt as a therapeutic target in cancer
Steelman, L. S., Stadelman, K. M., Chappell, W. H., Horn, S., Bäsecke, J., Cervello, M., Nicoletti, F., Libra, M., Stivala, F., Martelli, A. M., et al. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1139 · Cited by 141 · see citing works
Brooks, R., Fuhler, G. M., Iyer, S., Smith, M. J., Park, M.-Y., Paraiso, K. H. T., Engelman, R. W., & Kerr, W. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902844 · Cited by 140 · see citing works
Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis
Stiles, B. L., Gilman, V., Khanzenzon, N., Lesche, R., Li, A., Qiao, R., Liu, X. Z., & Wu, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3842-3851.2002 · Cited by 137 · see citing works
Duan, M., Li, W. C., Vlahos, R., Maxwell, M. J., Anderson, G. P., & Hibbs, M. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200660 · Cited by 133 · see citing works
Cuadrado, E., van den Biggelaar, M., de Kivit, S., Chen, Y.-Y., Slot, M., Doubal, I., Meijer, A., van Lier, R. A. W., Borst, J., & Amsen, D. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.008 · Cited by 132 · see citing works
AKT Signaling in Physiology and Disease
Vasudevan, K. M., & Garraway, L. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_66 · Cited by 131 · see citing works
Dong, F., & Larner, A. C. (2000) · Blood · doi:10.1182/blood.v95.5.1656.005k29_1656_1662 · Cited by 131 · see citing works
Lipid phosphatases in the immune system
Krystal, G. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0222 · Cited by 131 · see citing works
Becker, E., Huynh‐Do, U., Holland, S. J., Pawson, T. J., Daniel, T. O., & Skolnik, E. Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1537-1545.2000 · Cited by 131 · see citing works
Regulation of granulopoiesis by transcription factors and cytokine signals
Ward, A. C., Loeb, D., Soede-Bobok, A. A., Touw, I., & Friedman, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401808 · Cited by 131 · see citing works
Whitlock, B. B., Gardai, S. J., Fadok, V. A., Bratton, D. L., & Henson, P. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1305 · Cited by 131 · see citing works
Ivo, P. T. (2006) · Frontiers in bioscience · doi:10.2741/2103 · Cited by 130 · see citing works
Kalesnikoff, J., Baur, N., Leitges, M., Hughes, M. R., Damen, J. E., Huber, M., & Krystal, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4737 · Cited by 130 · see citing works
Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT
Leszczyńska, K. B., Foskolou, I. P., Abraham, A., Anbalagan, S., Tellier, C., Haider, S. A., Span, P. N., O’Neill, E. E., Buffa, F. M., & Hammond, E. M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80402 · Cited by 129 · see citing works
PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
Besson, A., Robbins, S. M., & Yong, V. W. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00542.x · Cited by 129 · see citing works
KIMBER, W. A., Trinkle‐Mulcahy, L., Cheung, P., Deák, M., MARSDEN, L. J., Kieloch, A., Watt, S. A., Javier, R. T., Alex, G. R. A. Y., Downes, C. P., et al. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610525 · Cited by 129 · see citing works
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
Luo, J.-M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402725 · Cited by 127 · see citing works
Dong, S., Corre, B., Foulon, E., Dufour, E., Veillette, A., Acuto, O., & Michel, F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060650 · Cited by 126 · see citing works
Prasad, N. K., Topping, R. S., & Decker, S. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1416-1428.2001 · Cited by 125 · see citing works
Freeburn, R. W., Wright, K. L., Burgess, S., Astoul, E., Cantrell, D. A., & Ward, S. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5441 · Cited by 121 · see citing works
Pauls, S. D., & Marshall, A. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646795 · Cited by 118 · see citing works
Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions
Subramanian, K. K., Jia, Y., Zhu, D., Simms, B. T., Jo, H., Hattori, H., You, J., Mizgerd, J. P., & Luo, H. R. (2007) · Blood · doi:10.1182/blood-2006-10-055319 · Cited by 118 · see citing works
Phosphoinositide phosphatases in cell biology and disease
Yang, L., & Bankaitis, V. A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.001 · Cited by 117 · see citing works
Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses
Ghansah, T., Paraiso, K. H. T., Highfill, S. L., Desponts, C., May, S. L., McIntosh, J. K., Wang, J.-W., Ninos, J. M., Brayer, J. B., Cheng, F., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7324 · Cited by 104 · see citing works
Li (2009) · International Journal of Oncology · doi:10.3892/ijo_00000306 · Cited by 101 · see citing works
The role of SHIP in cytokine-induced signaling
Kalesnikoff, J., Sly, L. M., Hughes, M. R., Büchse, T., Rauh, M. J., Cao, L.-P., Lam, V., Mui, A., Huber, M. C., & Krystal, G. (2003) · Springer eBooks · doi:10.1007/s10254-003-0016-y · Cited by 101 · see citing works
Harder, K. W., Quilici, C., Naik, E., Inglese, M., Kountouri, N., Turner, A. L., Zlatic, K., Tarlinton, D. M., & Hibbs, M. L. (2004) · Blood · doi:10.1182/blood-2003-12-4396 · Cited by 99 · see citing works
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 95 · see citing works
Kisseleva, M. V., Cao, L., & Majerus, P. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105969200 · Cited by 95 · see citing works
Activation of SHIP by NADPH Oxidase-stimulated Lyn Leads to Enhanced Apoptosis in Neutrophils
Gardai, S. J., Whitlock, B. B., Helgason, C. D., Ambruso, D., Fadok, V. A., Bratton, D. L., & Henson, P. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110005200 · Cited by 94 · see citing works
Nakamura, K., Malykhin, A., & Coggeshall, K. M. (2002) · Blood · doi:10.1182/blood-2002-03-0787 · Cited by 94 · see citing works
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
Mager, L. F., Riether, C., Schürch, C. M., Banz, Y., Wasmer, M.-H., Stuber, R., Theocharides, A. P. A., Li, X., Xia, Y., Saito, H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77347 · Cited by 93 · see citing works
Dilek, N., de Silly, R. V., Blancho, G., & Vanhove, B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00208 · Cited by 93 · see citing works
Gurung, R., Tan, A. W., Ooms, L. M., McGrath, M. J., Huysmans, R. D., Munday, A. D., Prescott, M., Whisstock, J. C., & Mitchell, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209991200 · Cited by 93 · see citing works
Choi, Y., Zhang, J., Murga, C., Yu, H., Koller, E., Monia, B. P., Gutkind, J. S., & Li, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205650 · Cited by 93 · see citing works
Phosphoinositide Phosphatases: Just as Important as the Kinases
Dyson, J. M., Fedele, C. G., Davies, E. M., Becanovic, J., & Mitchell, C. A. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_7 · Cited by 93 · see citing works
Targeting c-Kit mutations: basic science to novel therapies
Sattler, M., & Salgia, R. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.10.004 · Cited by 92 · see citing works
Portrait of PTEN: Messages from mutant mice
Suzuki, A., Nakano, T., Mak, T. W., & Sasaki, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00670.x · Cited by 91 · see citing works
Self-citationNabata, A., Kuroki, M., Ueba, H., Hashimoto, S., Umemoto, T., Wada, H., Yasu, T., Saito, M., Momomura, S., & Kawakami, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.003 · Cited by 87 · see citing works
SHIP1 and Lyn Kinase Negatively Regulate Integrin αIIbβ3 Signaling in Platelets
Maxwell, M. J., Yuan, Y., Anderson, K. E., Hibbs, M. L., Salem, H. H., & Jackson, S. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400746200 · Cited by 86 · see citing works
Tu, Z., Ninos, J. M., Ma, Z., Wang, J., Lemos, M. P., Desponts, C., Ghansah, T., Howson, J. M., & Kerr, W. G. (2001) · Blood · doi:10.1182/blood.v98.7.2028 · Cited by 82 · see citing works
Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5
Xiao, W., Hong, H., Kawakami, Y., Lowell, C. A., & Kawakami, T. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34013 · Cited by 82 · see citing works
Phosphoinositide phosphatases in a network of signalling reactions
Bléro, D., Payrastre, B., Schurmans, S., & Erneux, C. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0304-5 · Cited by 80 · see citing works
mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif
Wu, Y., Ouyang, W., Lazorchak, A. S., Liu, D., Shen, H., & Su, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219923 · Cited by 79 · see citing works
Vedham, V., Phee, H., & Coggeshall, K. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4211-4220.2005 · Cited by 76 · see citing works
Inositol Polyphosphate Phosphatases in Human Disease
Hakim, S., Bertucci, M. C., Conduit, S. E., Vuong, D. L., & Mitchell, C. A. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-94-007-5025-8_12 · Cited by 76 · see citing works
Mao, M., Fang, X., Lu, Y., LaPushin, R., Bast, R. C., & Mills, G. B. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520475 · Cited by 76 · see citing works
- Authors
- Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M.
- Affiliations
- University of Toronto (CA)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-04-01
- Volume
- 13
- Issue
- 7
- Pages
- 786-791
- ISSN
- 0890-9369 (ISSN-L)
- PMC
- PMC316591
- OpenAlex
- W2151313755
- Cited by
- 341
- References
- 31
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 10 · 2017: 8 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 14 · 2012: 17
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ships, inositol polyphosphate 5-phosphatase, phosphatidylinositol 3-kinase, phosphatidylinositol 3,4,5-trisphosphate, Akt signaling, apoptosis, GM-CSF receptor, growth factor withdrawal, myeloid hyperplasia, splenomegaly, mast cells, neutrophils
- MeSH terms
- Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Animals, Anisomycin, Bone Marrow, Cell Line, Cell Survival, Cycloheximide, Enzyme Activation, Interleukin-3, Mice, Inbred C57BL, Neutrophils, Phosphoric Monoester Hydrolases, Precipitin Tests, Proto-Oncogene Proteins, Sorbitol, Spleen, Time Factors, Blotting, Southern, Blotting, Western, Down-Regulation, Apoptosis, Protein Serine-Threonine Kinases, Mice, Knockout, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review